Zühlke Ventures

Zühlke Ventures is the venture capital arm of the Zühlke Group, focusing on early-stage investments in the HealthTech sector. The firm aims to identify promising startups and provide them with the necessary resources and expertise to succeed in the market. With a strong emphasis on innovation and technology, Zühlke Ventures seeks to empower entrepreneurs to bring their ideas to life and make a positive impact on the healthcare industry.

The investment strategy of Zühlke Ventures involves taking minority stakes in startups, with initial investments ranging from CHF 150,000 to CHF 250,000 per company. The firm operates primarily in Switzerland and Europe, with additional interests in the United States. Zühlke Ventures collaborates closely with its portfolio companies, offering access to the extensive network and expertise of the Zühlke Group to support their growth and development.

Over the years, Zühlke Ventures has built a diverse portfolio of HealthTech companies, including Aluna, Distalmotion, Droplette, Evismo, FLOW, Hystrix Medical, Indivi, Koya, Noctrix Health, Tenon, Bottneuro, Limula, PeriVision, DSwiss, and LMD. These investments reflect the firm's commitment to advancing healthcare through innovative technologies and solutions. By leveraging its deep industry knowledge and resources, Zühlke Ventures continues to play a pivotal role in shaping the future of healthcare innovation.